undefined undefined
NaN.000
NaN.00%
Arbutus Biopharma (NASDAQ:ABUS) quickly soared 15% after a win in a Covid vaccine patent dispute with Moderna (NASDAQ:MRNA), according to a court filing on Wednesday. Moderna fell 0.5%. The patent dec...
04-04 00:27
Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uveitis. Week 24 data show promising efficacy, with lower treatment failure rates and positive secondary endpoints. Roivant authorizes a $1.5 billion share repurchase program
04-03 00:31
Shares of Roivant (NASDAQ:ROIV) rose 6% in premarket trading Tuesday after the biotech group announced a $1.5B share buyback program and released positive data for its drug brepocitinib. Roivant’s boa...
04-02 21:20
Gainers: XTI Aerospace (XTIA) +85%. Kidpik (PIK) +46% announce entry into a definitive merger agreement. Ashford (AINC) +61% BOARD OF DIRECTORS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON...
04-02 20:25
格隆汇3月27日|生物制药公司Roivant Sciences(ROIV.US)涨6.65%,报10.75美元。消息面上,Roivant Sciences获纳入...
03-27 22:18
What is a Value Stock? A value stock is traditionally defined in terms of how i...
02-19 22:42
Ratings for Roivant Sciences (NASDAQ:ROIV) were provided by 4 analysts in the p...
02-15 01:00
HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and lowers the price target from $18 to $17.
02-15 00:47
Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.32) by 34.38 percent. The company reported quarterly sales of $37.14 million which beat the
02-13 21:12
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
02-13 18:05